Kidney International Reports · 2021 · 70 citations · 18 references
MedicineInternal MedicineNephrologyCritical Care PharmacologyHemodialysisPediatric NephrologyChronic Kidney DiseasePotassium BalancePotassium HomeostasisRenal DiseaseRenal Function TestsChronic Kidney Disease EpidemiologyCohort Study InvestigationIntensive Care Unit MortalityPotassium Concentration MeasurementPotassium ContentPotassium ExcessPotassium Homeostasis AbnormalitiesPropensity Score Adjustment
IntroductionHyperkalemia is a common, potentially life-threatening condition in patients with chronic kidney disease (CKD). We studied the association between hyperkalemia and mortality, cardiovascular events, hospitalizations, and intensive care unit (ICU) admissions.MethodsWe performed a retrospective cohort study using administrative databases in Manitoba, Canada. All adults (≥18 years of age) with potassium tests between January 2007 and December 2016 were included, with follow-up until March 31, 2017. Propensity score matching was performed among patients with de novo hyperkalemia (serum potassium ≥ 5.0 mmol/l) and patients who were nonhyperkalemic. The association between hyperkalemia and normokalemia and mortality was assessed using multivariate Cox proportional hazards regression models, adjusting for patient characteristics in a 1:1 propensity score–matched sample. Secondary outcomes included cardiovascular events, hospitalizations, and ICU admissions. A sensitivity analysis was performed with hyperkalemia defined as serum potassium ≥ 5.5 mmol/l.ResultsOf 93,667 patients with de novo hyperkalemia, 36% had diabetes mellitus (DM), 28% had CKD, and 21% had heart failure (HF). In the propensity score–matched sample of 177,082 individuals, hyperkalemia was associated with an increased risk for all-cause mortality (hazard ratio [HR] 1.15 [95% confidence interval {CI} 1.13–1.18], P < 0.001), cardiovascular events (HR 1.20 [95% CI 1.14–1.26], P < 0.001), short-term mortality (odds ratio [OR] 1.29 [95% CI 1.24–1.34], P < 0.001), hospitalizations (OR 1.71 [95% CI 1.68–1.74]), and ICU admissions (OR 3.48 [95% CI 3.34–3.62], P < 0.001). Findings were unchanged when a threshold of serum potassium ≥ 5.5 mmol/l was used.ConclusionHyperkalemia was an independent risk factor for all-cause mortality, cardiovascular events, hospitalizations, and ICU admissions. This finding expands our understanding of important clinical outcomes associated with hyperkalemia.
18
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn, Min Zhan, Van Doren Hsu et al. · Archives of Internal Medicine · 2009 · 643 citations · Full text
Medicine, Nephrology, Pharmacology +12
Sodium Zirconium Cyclosilicate in Hyperkalemia
David Packham, Henrik Rasmussen, Philip T. Lavin et al. · New England Journal of Medicine · 2014 · 493 citations · Full text
Allan J. Collins, Bertram Pitt, Nancy L. Reaven et al. · American Journal of Nephrology · 2017 · 403 citations · Full text
Medicine, Biostatistics, Nephrology +17